Bio-Techne Corp (TECH) Q3 2025 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Bio-techne Corp.

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:05.095 morning and welcome to Biotechnics Earnings Conference Call for the third quarter of 00:00:05.095 -- 00:00:07.716 fiscal year 2025. 00:00:08.038 -- 00:00:12.442 At this time, all participants have been placed in listen-only mode and the call will 00:00:12.442 -- 00:00:16.606 be open for questions following the management's prepared remarks. 00:00:16.606 -- 00:00:22.070 During our Q&A session, please limit yourself to one question and a follow-up. 00:00:22.070 -- 00:00:27.095 I would now like to turn the call over to David Clare, Biotechnics Vice President, Investor 00:00:27.095 -- 00:00:30.052 Relations. Please go ahead. 00:00:30.052 -- 00:00:32.154 Good morning and thank you for joining us. 00:00:32.154 -- 00:00:36.918 On the call with me this morning are Kim Kelderman, President and Chief Executive Officer, 00:00:36.918 -- 00:00:40.621 and Jim Hippel, Chief Financial Officer of Biotechni. 00:00:40.621 -- 00:00:44.885 Before we begin, let me briefly cover our safe harbor statement. 00:00:44.885 -- 00:00:49.388 Some of the comments made during this conference call may be considered forward looking 00:00:49.388 -- 00:00:53.192 statements, including beliefs and expectations 00:00:53.192 -- 00:00:56.374 about the company's future results. 00:00:56.374 -- 00:00:59.988 The company's 10K for fiscal year 2024 00:00:59.988 -- 00:01:05.474 identifies certain factors that could cause the company's actual results to differ materially 00:01:05.474 -- 00:01:10.659 from those projected in the forward-looking statements made during this call. 00:01:10.659 -- 00:01:15.204 The company does not undertake to update any forward-looking statements because of any 00:01:15.204 -- 00:01:18.687 new information or future events or developments. 00:01:18.687...